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ABSTRACT
The Mi-2/NuRD complex is a multi-subunit protein
complex with enzymatic activities involving chroma-
tin remodeling and histone deacetylation. Targeting
of Mi-2/NuRD to methylated CpG sequences medi-
ates gene repression. The function of p66a and of
p66b within the multiple subunits has not been
addressed. Here, we analyzed the in vivo function
and binding of both p66-paralogs. Both factors func-
tion in synergy, since knocking-down p66a affects
the repressive function of p66b and vice versa. Both
proteins interact with MBD2 functionally and bio-
chemically. Mutation of a single amino acid of p66a
abolishes in vivo binding to MBD2 and interferes
with MBD2-mediated repression. This loss of bind-
ing results in a diffuse nuclear localization in con-
trast to wild-type p66a that shows a speckled
nuclear distribution. Furthermore, wild-type subnuc-
lear distribution of p66a and p66b depends on the
presence of MBD2. Both proteins interact with the
tails of all octamer histones in vitro, and acetylation
of histone tails interferes with p66 binding. The con-
served region 2 of p66a is required for histone tail
interaction as well as for wild-type subnuclear dis-
tribution. These results suggest a two-interaction
forward feedback binding mode, with a stable chro-
matin association only after deacetylation of the
histones has occurred.
INTRODUCTION
DNA methylation at the 50-position of cytosine within CpG
dinucleotides has been shown to mediate long-term trans-
criptional repression of transposons, imprinted genes and
of the inactive X chromosome in female mammals (1).
Furthermore, CpG methylation is often found in the context
of tissue-speciﬁc genes in non-expressing tissues. Similarly,
DNA hypomethylation of the genome as well as methylation-
dependent silencing of tumor suppressor genes is often found
in human cancer (2–5). The molecular mechanism of DNA
methylation-mediated gene repression has been shown to
involve several aspects. In addition to changing the DNA
structure (6), binding of several regulatory factors is inﬂu-
enced or inhibited. This has been shown for the DNA binding
factors NF-kB (7), E2F (8), CpG binding protein CGBP (9),
GABP (10,11), CREB (12), as well as for the insulator fac-
tor CTCF (13,14). Although in these cases an inhibition of
DNA binding has been clearly shown to be involved in gene
repression, this mechanism seems to be restricted to a small
group of genes and regulatory sequences. The most com-
monly observed mechanism of DNA methylation-mediated
transcriptional repression involves modiﬁcation of the chro-
matin structure. A family of DNA binding proteins harboring
a methyl-CpG-binding domain (MBD) recognizes and binds
to methylated CpG sequences (15).
The MBD-containing family members MeCP2, MBD1,
MBD2 and MBD3 recruit histone deacetylases (HDAC),
which in turn deacetylate histone tails resulting in the genera-
tion of a repressive chromatin conformation (16–19). MeCP2
interacts with the Sin3A histone deacetylase complex (20,21).
It has recently been shown that MeCP2-mediated repression
is associated with the chromatin remodeling complex SWI/
SNF, which is possibly involved in changing the chromatin
architecture such that histone deacetylases can act on histone
tails (22). Similarly, within the MeCP1 complex, MBD2 is
associated with the Mi-2/NuRD complex that contains histone
deacetylases as well as chromatin remodeling factors (18,23).
In contrast to MeCP2, the MBD3 factor of the Mi-2/NuRD
complex is unable to bind to methylated CpG sequences in
mammals, instead this complex associates with MBD2, which
in turn binds to methylated CpGs (18,19). Besides MBD3, the
Mi-2/NuRD complex consists of the histone deacetylases
HDAC1 and HDAC2 together with the retinoblastoma-
associated proteins RbAp46 and RbAp48. These factors are
central components of the Mi-2/NuRD complex, the Sin3A
complex, as well as of other chromatin associated complexes
[reviewed in (24)]. In addition, MTA2as well as the chromatin
remodeling factor Mi-2 together with p66 are components of
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small gene family coding for p66a and p66b, both of which
interact with MBD2 as well as with MBD3 (25). We wished
to analyze the functional interplay between p66a and p66b
in the context of MBD2-mediated repression. The results
show that p66a and p66b target to DNA bound MBD2 as
well as to unmodiﬁed, deacetylated histones. Both functions
are mediated by separate domains, both of which are required
for wild-type distribution within the nucleus.
MATERIALS AND METHODS
Plasmids
pABGal-hp66a and pABGal-hp66b were constructed as
described previously (25). pSG5-hp66a was generated by
subcloning the EcoRI/XbaI fragment from pOTB7-hp66a
(25) into pSG5 (Stratagene) opened with EcoRI/BamHI.
pSG5-hp66b was cloned by ligating the EcoRI/BamHI frag-
ment of pABGal-hp66b into pSG5. C-terminal deletions of
pSG5-hp66a were generated by digesting the full-length
construct with BglII/EheI (amino acids 1–433), BglII/BcuI
(amino acids 1–329) or BglII/SacI (amino acids 1–238) and
religating the blunted ends. For pSG5-hp66a 134–633 the
BspHI/XbaI fragment from pOTB7-hp66a was cloned
in-frame into pABGal94 linker (26) to generate pABGal-
hp66a 134–633 which was then digested with EcoRI/
BamHI and ligated into pSG5. CR2 of hp66a was ampliﬁed
with primers 50-GCCGAGGATCCAGCAAGCATGCAGGC-
30 and 50-GCCGAGATCTGCTGCAGGAGCCGCT-30, the
product was digested with BamHI/BglII and ligated into
pSG5 to generate pSG5-hp66a 344–480. For transfections,
the 4xUAStk luciferase reporter construct and expression
plasmid pCMV-lacZ encoding b-galactosidase were kindly
provided by A. Baniahmad. pEGFP-hp66a was constructed
by ligating the SalI/BamHI fragment from pAB-Gal94-hp66a
into pEGFP-C1 (Clontech). pEGFP-hp66a 1–482 or 1–348
were ampliﬁed with the sense primer 50-TGCAGTCGACCA-
TATGACCGAAGA-30 and the antisense primers 50-CGGA-
TCCTGCTGCAGGAGCC-30 or 50-GCGGATCCGCTTGCT-
GGAGACT-30, respectively. Products were then digested
with SalI/BamHI and ligated into pEGFP-C1. Construction
of pEGFP-hp66b was described previously (25). C-terminal
deletions pEGFP-hp66b 1–489 and 1–354 were generated via
PCR with sense primer 50-TGCAGTCGACATGGATAGAA-
TGACAGA-30 and antisense primers 50-GGGATCCCTGCT-
GCTGTAATCG-30 and 50-GCTGGATCCTGTGAGTTGG-
CAG-30, respectively. The generated products were treated
with SalI/BamHI and cloned into pEGFP-C1. Cloning of
pABGal-MBD2b was explained earlier (16). pSil-aX was
cloned by annealing oligos 50-GATCCGGAACAGGAGATT-
GAGCAGTTCAAGAGACTGCTCAATCTCCTGTTCCTT-
TTTTTGGAAA-30 and 50-AGCTTTTCCAAAAAACAGGA-
ACAGGAGATTGAGCAGTCTCTTGAACTGCTCAATCT-
CCTGTTCCG-30 and ligating the product into pSilencer
2.1-U6 neo (Ambion) digested with BamHI/HindIII. pSil-
bX was created using oligos 50-GATCCGGAGGATTTGG-
CAAATCTTTCAAGAGAAGATTTGCCAAATCCTTCCT-
TTTTTGGAAA-30 and 50-AGCTTTTCCAAAAAAGGAA-
GGATTTGGCAAATCTTCTCTTGAAAGATTTGCCAAA-
TCCTTCCG-30 into pSilencer 2.1-U6 neo opened with
BamHI/HindIII. pABGal-p66a with single amino acid sub-
stitution K149R was constructed using the QuikChange
site-directed mutagenesis kit (Stratagene) according to the
manufacturer’s instructions with the sense primers 50-GG-
ATGATCAAGCAGCTGAGGGAAGAATTGAGGTTAG-30
and antisense primers 50-CTAACCTCAATTCTTCCCTCAG-
CTGCTTGATCATCC-30. The enhanced green ﬂuorescent
protein (EGFP) fusion of p66aK149R was generated by cut-
ting the SalI/BamHI fragment of pABGal-p66aK149R and
insertion into pEGFP-p66a cut with SalI/BamHI. pSG5-
p66aK149R was created by ligation of the SalI/BamHI frag-
ment from pABGal-p66aK149R into pSG5-p66b digested
with SalI/BamHI. Plasmids for the bacterial expression of
glutathione S-transferase (GST)-fused histone tails (pGEX1-
H2A, pGEX1-H2B, pGEX1-H3, pGEX1-H4) were gratefully
received from C. Wu (27); constructs pGEX-2T-p300 and
pGEX-5X-PCAF for the expression of the HAT-domains of
GST-p300 and GST-PCAF were obtained from S. Berger (28).
Generation of pCMV-GST-MBD2b for eukaryotic protein
expression was presented previously (25).
Cell culture and transfections
All cells were cultured in DMEM with 10% fetal calf serum at
37 C, 5% CO2. Transfection of HeLa cells was carried out
using the CaPO4 method as described elsewhere (29). Cells
were cotransfected in 6-well plates (10
5 cells/well) using
0.75–1.5 mg of 4xUAStk-luciferase reporter plasmid, 0.2 mg
of pCMV-lacZ encoding b-galactosidase and 0.75–1.5 mgo f
expression plasmids. For reporter assays, knock-down of
hp66-expression was achieved with 0.5–2.0 mg of pSil-aX
or pSil-bX. Cells were harvested 36–96 h after transfection
and assayed for luciferase and b-galactosidase activity. All
transfection assays shown were performed in duplicates or
triplicates and repeated at least twice. Transfection of NIH
3T3 cells and MBD2( / ) and wild-type tail ﬁbroblasts
[kindly provided by A. Bird (30)] was performed using jetPEI
(Polyplus transfection) according to the manufacturer’s pro-
tocol. For ﬂuorescent imaging, cells were grown on cover slips
in 6-well dishes (10
5 cells/well) and transfected with 3 mgo f
pEGFP-constructs. Images were taken 24–48 h post-
transfection using 100-fold magniﬁcation after incubation
with ‘Hoechst DNA stain’ for 10 min at 37 C. Signiﬁcance
of observed changes in reporter gene activity has been determ-
ined by the Dunnett’s t-test and Tukey’s studentized range
(HSD) test, depending on the type of data analyzed.
Immunoblotting
For analysis of reduced protein expression, HeLa cells were
transfected in 10 cm dishes (1 · 10
6 cells/dish) with 15 mgo f
pSil-aX, pSil-bX and pSil-neg together with 15 mg pBSK
(Stratagene). Nuclear extracts were prepared 96 h post-
transfection essentially as described previously (31). Cells
were resuspended in 3 vol of buffer A (20 mM HEPES,
pH 7.9, 10% glycerol, 0.2% NP-40, 10 mM KCl and 1 mM
EDTA). After centrifugation at 5000 g for 10 min at 4 C, the
supernatant was discarded and the remaining nuclei pellet
resuspended in 2 vol buffer B (420 mM NaCl, 20 mM
HEPES, pH 7.9, 10 mM KCl and 1 mM EDTA), followed
by rotational incubation for 30 min at 4 C. To remove cell
debris, the extract was centrifuged at 20000 g for 15 min at
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and analyzed by western blotting with an anti-p66 antibody
(Upstate).
Mammalian pull-down
HEK293 cells were transiently cotransfected with mammalian
expression vectors for pCMV-GST, pCMV-GST-MBD2b
with Gal, Gal-p66a or Gal-p66aK149R. Cells were collected
48 h after transfection, and nuclear extracts was performed
according to the protocol described above. Aliquots contain-
ing 400 mg of the nuclear extract were incubated with 40 ml
glutathione–Sepharose 4B beads (Amersham Biosciences)
for 30 min at room temperature. The beads were washed
four times with washing buffer (200 mM NaCl, 20 mM
Tris–HCl, pH 8.0, 1 mM EDTA and 0.5% NP-40). Proteins
binding to the beads were eluted with SDS sample buffer,
separated on SDS–PAGE and subsequently detected by
western blotting with anti-Gal4 polyclonal IgG antibody.
The ECL  kit (Amersham Biosciences) was used to visualize
the proteins on the membrane following the manufacture’s
protocol.
GST pull-down of in vitro translated proteins
GST and GST-histone tails were expressed in Escherichia
coli BL21. GST pull-downs were carried out essentially as
described previously (16). Bacteria were induced with
0.2 mM isopropyl-b-D-thiogalactopyranoside (IPTG) for 3 h
at20 C.Recombinant proteinswere puriﬁedwith glutathione–
Sepharose beads (Amersham Biosciences) and analyzed on
SDS–PAGE to normalize protein amounts. Equivalent
amounts of GST fusion proteins were incubated with
[
35S]methionine-labeled hp66-proteins, produced by the T7/
T3 TNT-coupled transcription/translation system (Promega)
in 200 ml of binding buffer (100 mM NaCl, 20 mM Tris–
HCl, pH 8.0, 1 mM EDTA, 0.5% NP-40, 5 mg of ethidium
bromide and 100 mg of BSA). After 30 min of incubation at
room temperature, the beads were washed ﬁve times with
1 ml of binding buffer without ethidium bromide and BSA.
The bound proteins were eluted with SDS sample buffer,
fractionated on SDS–PAGE and visualized by ﬂuorography.
Acetylation-dependent interaction
For the acetylation of histone tails GST-p300 and GST-PCAF
were expressed in E.coli BL21 cells after induction with
IPTG for 5 h at 20 C. The pellet of a 400 ml culture was
resuspended in 30 ml STE-buffer (150 mM NaCl, 10 mM
Tris–HCl, pH 8.0, 1 mM EDTA) and slowly frozen at
 20 C. About 1.2 ml lysis buffer (250 mM MgCl2,2 5m M
MnCl2, 250 mg/ml DNase I, 250 mg/ml RNase A and 12 mg/ml
lysozyme) were added after thawing and incubated for
30 min at 4 C while rotating. Cell debris was pelleted by
centrifugation for (30 min, 10000 g,4  C) and the supernatant
incubated with 200 ml of 50% glutathione–Sepharose beads
(Amersham Biosciences) for 1 h at 4 C. The beads were
washed three times with washing buffer (100 mM Tris–
HCl, pH 8.0, 100 mM NaCl) and the recombinant proteins
eluted with 200 ml of elution buffer (20 mM reduced gluta-
thione, 100 mM Tris–HCl, pH 8.0, 100 mM NaCl) by
incubating for 1 h at 4 C and subsequently for 1 h at 20 C.
After centrifuging, the glutathione was removed by YM-10
Microcon columns according to the manufacturer’s protocol
(Millipore). Extracts were stored with 20% glycerol at  80 C.
To determine the acetylation pattern of the puriﬁed HAT-
extracts, 2–3 mg of recombinant GST-histone tails were
incubated for 0.5–2 h at 30 C with 1–2 mg of GST-PCAF
or GST-p300 in 30 ml of acetylation buffer (50 mM Tris–
HCl, pH 8.0, 5% glycerol, 1 mM DTT and 10 mM Na
Butyrate) together with 1 mCi [
3H]Acetyl-CoA. Samples
were fractionated on SDS–PAGE and visualized by
ﬂuorography.
Analysis of acetylation-dependent interaction with histone
tails was performed by acetylating glutathione–Sepharose
bound GST-histone tails with non-labeled Acetyl-CoA essen-
tially as described above or by treating a second set of
histone tails without Acetyl-CoA. Both sets of histone tails
were then incubated with in vitro translated [
35S]methionine-
labeled hp66a or hp66b proteins. Subsequently, all samples
were treated according to the GST pull-down protocol
described above.
RESULTS
MBD2-mediated repression is increased by p66a and
p66b
We have previously reported that the paralogous proteins
p66a and p66b share a high degree of sequence homology
that has been conserved throughout evolution. In addition,
both paralogs have been identiﬁed as being interaction
partners of the methyl-CpG-binding protein MBD2 (25,32).
Since Gal-fusions of p66a and p66b were shown to repress
transcription of a UAS-reporter construct, we investigated
the functional association of these paralogous proteins with
MBD2. We ﬁrst analyzed the inﬂuence of p66a and p66b
on MBD2-mediated repression. MBD2 was fused to a
GAL4 DNA binding domain (Gal-DBD) and transfected
into HeLa cells together with increasing amounts of p66a
or p66b and an appropriate luciferase reporter containing
four GAL4 DNA binding sites (UAS). In agreement with
previous reports (16), Gal-MBD2 repressed reporter activity
by  14-fold in the absence of any cotransfected p66-
constructs (Figure 1). MBD2-mediated repression was, how-
ever,enhanced in a dose-dependent manner up to 45-fold upon
transfection of increasing amounts of p66a. Overexpression
of p66b increased the repression of Gal-MBD2 up to  28-
fold. As a result, both p66-proteins are capable of enhancing
MBD2-mediated repression, with the enhancement by p66a
being stronger than by p66b.
In order to further characterize the inﬂuence of the p66-
paralogs on MBD2-mediated repression, a second approach
that involved knocking down of endogenous p66a and p66b
using RNAi and analyzing subsequent alterations of MBD2
function was performed. Using a vector driven shRNAi-
procedure, target sequences were identiﬁed that resulted in
a speciﬁc decrease of p66a or p66b expression. HeLa cells
were either transfected with constructs targeting p66a (pSil-
aX), p66b (pSil-bX) or a non-targeting control sequence
(pSil-neg) and analyzed for p66-expression using western
blot analyses (Figure 2A). Since p66a and p66b exhibit
molecular weights of 68 and 66 kDa, respectively, both pro-
teins could be separated via SDS–PAGE and simultaneously
Nucleic Acids Research, 2006, Vol. 34, No. 2 399identiﬁed using an antibody recognizing both p66a and
p66b. Figure 2A demonstrates that the expression of p66a
or p66b is clearly reduced 96 h after RNAi treatment. Import-
antly, knock-down of one p66-protein does not inﬂuence the
expression of the other homologous partner, demonstrating
that the expression levels of both p66-proteins are indepen-
dent from one another and that each protein can be knocked
down speciﬁcally using the shRNAi-approach.
Having established suitable conditions for p66-knock-
down, HeLa cells were transfected with plasmids coding either
for Gal-DBD or for a Gal-MBD2 fusion and knock-down
plasmids pSil-aX and pSil-bX (Figure 2B). Gal-MBD2
repressed reporter activity by about 18-fold in the absence
of targeted knock-down. However, knocking down p66a by
cotransfecting pSil-aX relieved MBD2-mediated repression
to 11-fold, and similar results were achieved by reducing
p66b expression. Notably, combined knock-down of both
p66-proteins further abated MBD2-mediated repression
down to 8-fold. MBD2-mediated repression is therefore at
least partly dependent on p66a as well as on p66b and can
be inﬂuenced by overexpression or knock-down of both
paralogous proteins.
Enhancement of MBD2-mediated repression is
dependent on the direct interaction of MBD2 and p66a
Since both p66a and p66b inﬂuence repression by MBD2, we
next investigated whether this ﬁnding is the result of a direct
effect that is mediated by the interaction of the two homologs
with MBD2. The conserved region 1 (CR1) located at the
N-terminus of both p66-proteins has been shown to be an
interaction domain with MBD2, and we had previously iden-
tiﬁed a minimal overlapping region within the CR1 of p66a
that is required for this interaction (25). Database analysis
revealed a highly conserved candidate SUMOylation con-
sensus site contained within this sequence that is not pre-
sent in p66b. In order to disrupt this consensus sequence,
Figure 1. Expression of p66a or p66b increases MBD2-mediated repression.
HeLa cells were cotransfected with a 4xUAStk luciferase reporter together
with plasmids coding for the Gal-DNA binding domain, Gal-MBD2b and
no (mock) or increasing amounts of p66a (A) or p66b (B). Cell extracts were
analyzed for reporter gene activity. Fold repression was determined relative to
the Gal-DNA binding domain. Error bars represent variations within duplicate
transfections, significant changes relative to mock are indicated by asterisk.
Luciferase activity was measured 48 h after transfection.
Figure 2. Knock-down of endogenous p66a or p66b decreases MBD2-
mediated repression. (A) Endogenous expression of p66a and p66b is reduced
96 h after RNAi treatment. HeLa cells were transfected with either pSilencer
constructs targeting p66a (pSil-aX), p66b (pSil-bX), a non-targeting control
sequence (pSil-neg) or left untransfected (n.trans). Nuclear extracts were pre-
pared and subjected to western blotting using the p66 antibody. (B) MBD2-
mediated repression is reduced by knock-down of endogenous p66a or p66b.
HeLa cells were transfected with the indicated pSilencer constructs together
with expression vectors for the Gal-DNA binding domain or Gal-MBD2b and
the 4xUAStk luciferase reporter. Cell extracts were analyzed for reporter gene
activity. Fold repression was determined relative to the Gal-DNA binding
domain. Error bars represent variations within duplicate transfections, signifi-
cant changes relative to pSil-neg are indicated by asterisk.
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the hydrophilic characteristic of the region. Detailed analysis
of this mutant did not provide any evidence for SUMOyla-
tion of the wild-type site (data not shown). Nevertheless,
we analyzed the interaction of p66a-K149R with MBD2
in vivo. GST–MBD2 was coexpressed with Gal-fused
p66a-K149R in HEK 293 cells and nuclear extracts were
bound to glutathione–Sepharose beads. Coprecipitated pro-
teins were detected on western blots using an antibody direc-
ted against Gal-DBD. Figure 3A illustrates that wild-type
Gal-p66a precipitates with GST–MBD2. Although the mutant
protein is highly expressed in these cells, Gal-p66a-K149R
doesnotcoprecipitatewith MBD2. Furthermore, thismutant is
not able to enhance MBD2-mediated repression as observed
for the wild-type protein (Figure 3B). However, Gal-MBD2
repression in part mediated by p66a is slightly reduced,
possibly due to a dominant negative effect of the K149R
mutant. Taken together, these results suggest that the func-
tional enhancement of MBD2-mediated repression by p66
involves a direct interaction between MBD2 and p66a.
p66a and p66b repress transcription downstream of
MBD2
p66a and p66b are interaction partners with MBD2 and
have been identiﬁed as being components of the Mi-2/
NuRD complex.Functioningasthemethyl-CpG-binding com-
ponent, MBD2 is thought to target the Mi-2/NuRD complex
to methylated DNA. It should be possible to replace the
MBD2 function with the Gal-DNA binding domain fused
directly to either p66a or p66b in such a model. In order to
test this, GAL-fusion constructs of p66a or p66b were trans-
fected into wild-type mouse ﬁbroblast cells or into cells in
which MBD2 has been knocked-out (30). As illustrated in
Figure 4A, both p66-paralogs were able to repress transcrip-
tion of a cotransfected luciferase reporter gene in wild-type
Figure 3. K149 of p66a is required for the MBD2interactionas well as for the
MBD2-mediated repression. (A) HEK293 cells were harvested 48 h after
transfection with various combinations of DNA constructs, as indicated above
the figure. Nuclear protein extracts were prepared (input) and purified with
glutathione–Sepharose beads. The bound protein together with the input frac-
tionswereanalyzedbywesternblottingusingtheanti-Galantibody.(B)K149R
mutant of p66a decreases MBD2-mediated repression. HeLa cells were
cotransfected witha 4xUAStk luciferase reporter togetherwith vectors expres-
sing the Gal-DNA binding domain, or Gal-MBD2b and increasing amount of
pSG5-p66a or pSG5-p66aK149R. Fold repression was determined relative to
the Gal-DNA binding domain, significant changes relative to Gal-MBD2b
(asterisk) and relative to comparable amounts of p66a (open triangle) are
indicated.
Figure 4. p66a- or p66b-mediated repression acts downstream of MBD2.
Mouse fibroblasts (30) expressing wild-type MBD2 (MBD2+/+)( A)o r
MBD2 knock-out fibroblasts (MBD2 / )( B) were transfected with vectors
expressingtheGal-DNAbindingdomain,Gal-p66aorGal-p66b togetherwith
a4xUAStkluciferasereporter.SignificantchangesrelativetoGalareindicated
by asterisk.
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2-fold lower than that mediated by p66a. This difference
between p66a and p66b is less pronounced when compared
with CV-1 cells (25) and may reﬂect a cell-type speciﬁcity.
Interestingly, both Gal-p66a and Gal-p66b were able to rep-
ress transcription in an MBD2 /  environment (Figure 4B).
MBD2 /  cells were treated using identical conditions as
used for the wild-type cells. Both Gal-p66-proteins repres-
sed transcription, with p66a-mediated repression also being
about 2-fold stronger as compared with p66b-mediated
repression. While the overall repressive capacity of both pro-
teins is lower than in wild-type ﬁbroblasts, Gal-p66a and
Gal-p66b clearly still maintain their ability to repress tran-
scription. MBD2 is therefore not essential for the repression
by either Gal-p66a or Gal-p66b, and thus does not function as
a downstream factor for p66-mediated repression. Instead,
MBD2 acts as the DNA binding factor targeting p66a and
p66b to DNA.
p66a or p66b requires the paralogous p66 partner for
repression
Different approaches to purify the chromatin remodeling
complex Mi-2/NuRD have resulted in the identiﬁcation of
two proteins of 66 and 68 kDa with strong homologies to
the p66-component from Xenopus laevis. Although p66b
has been characterized as being a component of the human
Mi-2/NuRD complex,the associationofp66aandp66bwithin
the repressor complex had until now not been elucidated. In
order to investigate the organization of both p66-paralogs
within the repressor complex, the expression of one p66-
protein was knocked down and the inﬂuence on the repressing
activity of the paralogous partner was determined. HeLa cells
were transfected with Gal-p66a, Gal-p66b or the Gal4 DNA
binding domain alone together with an appropriate reporter
gene. Protein expression of p66a or p66b was speciﬁcally
reduced by cotransfecting pSil-aX or pSil-bX and reporter
gene activity was determined. As illustrated in Figure 5,
reducing the expression of p66a or p66a inﬂuences repres-
sion by the Gal-fused paralog. Transfection of pSil-aX
resulted in an expected decrease of Gal-p66a mediated
repression by more than 14-fold; however, repression by
p66b was also decreased by a factor of 2.4, compared with
a non-targeting knock-down construct (pSil-neg). Similarly,
knock-down of p66b not only decreased Gal-p66b media-
ted repression about 3-fold, but also relieved Gal-p66a
mediated repression by more than 4-fold. This effect could
be explained by a functional interplay between p66a and
p66b, consistent with the idea that both proteins function as
a part of the same complex.
Acetylation-sensitive association of p66a and p66b with
histone tails
Post-translational modiﬁcations of histone tails are known
to inﬂuence chromatin structure and gene expression (33).
Deacetylation of histone tails by the MeCP1 complex causes
chromatin condensation and transcriptional repression (34).
MBD2, the DNA binding component of MeCP1, has been
shown to associate with heterochromatin and to largely
colocalize with p66a and p66b (25). To address the question
whether chromatin association of the MeCP1 complex might
also be due to a direct interaction of the p66-proteins with
histones, GST-fused histone tails of H2A, H2B, H3 and H4
were used in an in vitro pull-down assay with radioacti-
vely labeled p66-constructs. In vitro translated p66a and
p66b showed a strong afﬁnity for all histone tails tested
(Figure 6). C-terminal deletions of p66a that removed a
part of or all of conserved region 2 (CR2) showed a reduced
afﬁnity for all histone tails tested. However, an N-terminal
deletion of p66a or CR2 alone still retained the capacity to
interact with histones. Although the CR2-domain is sufﬁcient
to mediate histone-tail interaction, the overall afﬁnity is
reduced compared with the full-length protein. This suggests
Figure 5. p66a or p66b requires the paralogous p66 partner for repression.
HeLa cells were transfected with plasmids coding for the Gal-DNA binding
domain, Gal-p66a or Gal-p66b together with pSil-neg, pSil-aX or pSil-bX.
Cell extracts were analyzed for reporter gene activity; fold repression was
determined relative to the Gal-DNA binding domain; significant changes
relative to pSil-neg are indicated by asterisk.
Figure 6. Both p66a and p66b interact with histone tails in vitro. GST and
GST-histone tails were purified with glutathione–Sepharose beads and ana-
lyzed by SDS–PAGE to normalize protein amounts. Equivalent amounts of
GST fusion proteins were incubated with [
35S]methionine-labeled in vitro
translatedp66-proteins,asindicatedleftofthefigure.Theboundproteinswere
eluted with SDS sample buffer, fractionated on SDS–PAGE and visualized by
fluorography.
402 Nucleic Acids Research, 2006, Vol. 34, No. 2that either a second interaction domain exists outside of CR2,
or that other regions of the protein stabilize the association
of the CR2-domain with histones.
Since the GST-histone tails used in these experiments
had been puriﬁed from bacteria, and therefore contained no
post-translationalmodiﬁcations,the histone-acetyltransferases
(HATs) p300 and PCAF were used to differentially modify
the N-terminal domains of the histones. In order to do so, the
acetyltransferase domains of p300 and PCAF fused to GST
were bacterially expressed and incubated with individual
histone tails. Radioactive labeled acetyl-CoA was used as
an acetyl-donor. Figure 7A depicts the speciﬁcity and intens-
ities with which the different enzymes acetylated the indi-
vidual substrates. While GST-p300 preferentially modiﬁed
the N-terminal region of histone H4 followed by H2A and
H3, GST-PCAF was autoacetylated (35) (seen in all lanes
at top of the ﬁgure) and acetylated mainly the histone tails
of H3 and to a lesser extent H4.
We next investigated whether this modiﬁcation altered
the binding capacity to p66a and p66b. Using a modiﬁed
GST pull-down assay, one set of histone-substrates was
acetylated by GST-p300 or GST-PCAF and another set
remained unmodiﬁed. Both sets were subsequently bound
to Sepharose beads and incubated with [
35S]labeled p66a
or p66b. Acetylation by p300 resulted in a considerable
reduction of retained p66a or p66b on the N-terminal domains
of histone H4, H2A and to a lesser degree H3 (Figure 7B and
C). The association of both p66-paralogs with the histone
tails was also decreased upon acetylation by the HAT-
domain of PCAF. Corresponding to the acetylation speciﬁ-
city of this acetyltransferase, the afﬁnity for histone H3
was reduced to a greater extent than for H4, whereas the
unmodiﬁed histone tails all bound similarly. We also found
an association of both p66-proteins with PCAF. Upon auto-
acetylation of E.coli expressed PCAF, the interaction
with either p66 is not reduced, rather slightly increased (see
Supplementary Data). This suggests that p66 loss of bind-
ing upon acetylation of histone tails is likely not due to an
unspeciﬁc charge effect of the acetyl groups since in the case
of PCAF acetylation the reverse effect is seen. Thus, the
afﬁnities of p66a and p66b for the N-terminal histone
regions are dependent on the modiﬁcation state; acetylation
of histone tails speciﬁcally reduces the association with both
p66-proteins.
Nuclear distribution of p66a and p66b depends on CR2
and MBD2
We have shown an in vitro association of p66a and p66b
with the N-terminal regions of histone tails and have identi-
ﬁed the conserved region 2 as a potential interaction domain.
To substantiate these ﬁndings in vivo, we constructed several
GFP-fused deletion constructs of both p66-paralogs and ana-
lyzed their localization in NIH 3T3 cells. Full-length p66-
GFP fusions as well as C-terminal deletions of up to the
CR2-domain of p66a (p66a 1–482) or p66b (p66b 1–489)
show a speckled distribution in the nucleus (Figure 8). How-
ever, deletion of the CR2-domain (p66a 1–348, p66b 1–344)
resulted in an overall loss of the speckled pattern and a uni-
form localization within the nucleus. The wild-type distribu-
tion of both paralogs is therefore dependent on CR2.
Because the CR1 domain of p66a and p66b has already
been shown to interact with MBD2 and a point mutation in
the CR1 domain of p66a (p66a K149R) disrupts MBD2-
binding (see above), we used this mutant to test the MBD2-
dependent distribution of p66a. Transfection of a GFP-p66a
K149R construct into NIH 3T3 cells resulted in a diffuse
nuclear localization. In order to provide further evidence
that the subnuclear localization of p66a and p66b depends
on the presence of MBD2, we compared the localization
of GFP-p66a and GFP-p66b in MBD-containing ﬁbroblasts
versus MBD2 /  ﬁbroblast cells (Figure 9). Similar to the
previously described distribution in HEK 293 cells, ﬁbroblasts
containing MBD2 displayed a speckled nuclear localization
of both GFP-p66-proteins. Interestingly, MBD2 knock-out
cells lacked the speckled pattern but displayed a diffuse nuc-
lear distribution. Taken together, these results are in agree-
ment with the notion of a dual mechanism that is responsible
for the localization of p66a and p66b. The interaction with
MBD2 via the CR1-domain as well as the presence of the CR2
simultaneously determine the distribution of the p66-paralogs.
DISCUSSION
Regulation of gene expression is largely inﬂuenced by DNA
methylation, histone modiﬁcations and chromatin structure.
Figure 7. Acetylation of histone tails reduces the association with both p66-
proteins in vitro.( A) The histone acetyltransferase domains of p300 and of
PCAF were bacterially expressed and incubated with individual GST-histone
tails together with radioactive acetyl-CoA. Glutathione–Sepharose purified
GST-histone tails were eluted with SDS sample buffer, fractionated on
SDS–PAGE and visualized by fluorography. p300 acetylated primarily
H2A, H3 and H4 histone tails, whereas PCAF acetylated primarily the tails
of histone H3, and also of H4. Acetylation by p300 or PCAF reduced associa-
tion of p66a (B) or of p66b (C) with acetylated histone tails. Acetylated
GST-histone tails as in (A), but incubated with non-radioactive acetyl-CoA
(+CoA) or non-acetylated histone tails ( CoA), were incubated with
[
35S]methionine-labeled in vitro translated p66-proteins. All samples were
purifiedbyglutathione–Sepharose,fractionatedon SDS–PAGEandvisualized
by autoradiography.
Nucleic Acids Research, 2006, Vol. 34, No. 2 403The repressor complex Mi-2/NuRD is thought to be targeted to
methylated DNA via MBD2 thereby generating the MeCP1
complex. The MeCP1 complex is composed of 10 subunits
including the methyl binding proteins MBD2 and MBD3, the
histone deacetylases HDAC1 and HDAC2, as well as two
proteins of 66 and 68 kDa. Although these p66/68 compo-
nents were originally hypothesized to be a single protein pos-
sibly differing in a post-translational modiﬁcation, we have
previously demonstrated that two homologous but distinct
p66a and p66b proteins exist in humans (25).
Here we show that, when tethered to DNA, transcriptional
repression by p66a or p66b does not require the methyl
binding protein MBD2. Overexpression of each p66-protein
augments repression by MBD2 and knock-down of either p66-
paralogs reduces repression by MBD2. Combined knock-
down of both p66-proteins decreases the repression by
MBD2 further. However, since repression by MBD2 is also
mediated by proteins other than the Mi-2/NuRD complex, a
complete relief of repression would not be expected using
this approach. These results indicate that the repressive func-
tion of MBD2 is mediated by the paralogous p66-proteins and
that this repression might depend on a synergistic function
with both p66a and p66b being present simultaneously in a
single complex.
The CR1-region of p66b has previously been shown to
interact with MBD2 and to be responsible for the integra-
tion of p66b within the MeCP1 complex (32). By mutating
CR1 of p66a, we identiﬁed a critical amino acid essential for
the interaction of p66a with MBD2 in vivo. Our observation
that this point mutant was unable to enhance MBD2-mediated
repression is in agreement with its inability to associate
with MBD2. Additionally, transfection of a GFP-fused mutant
resulted in a loss of the speckled nuclear localization observed
with the wild-type protein. Therefore, as is the case with
p66b, the CR1 of p66a is required for the association of
p66a with MBD2. An analysis of the distribution of GFP-
p66-proteins in the absence of MBD2, which revealed a
diffuse nuclear distribution as well, further supports this
view. MBD2 is therefore essential for the correct nuclear
localization of p66a as well as of p66b, and very likely rec-
ruits both proteins to their target sites via CR1.
Chromatin and histone tail association of Mi-2/NuRD has
been documented (36,37). Histone H3 K4 methylation pre-
vents NuRD binding, whereas H3 K9 methylation does not
(37). Here, we demonstrated that both p66-paralogs bind
directly to histone N-terminal tails in vitro, and that for
p66a this association requires CR2. The localization of
p66b has previously been shown to depend on CR2 (32).
As discussed below, histone tail interaction may be important
in mediating a two-interaction binding mode by DNA bound
MBD2 as well as by histone tail interaction. In such a scenario,
histone tail interaction may either be charge driven or may
require speciﬁc binding surfaces or both. Interestingly, acet-
ylation of histone N-termini by the histone acetyltransferases
p300 or PCAF abrogated the association with the p66-
proteins. The acetylation pattern by PCAF corresponds to
reports by other groups in which the N-terminus of histone
H3 (H3 K14) is preferentially modiﬁed over histone H4 (H4
K8) (38,39). Acetylation by p300 is known to differ from
PCAF in that H2A is modiﬁed at lysine 5 (H2A K5), H3 at
K14 and K18, and histone H4 at K5 and K8 (38,39). Although
p300 has been reported to acetylate H2B as well, we were
not able to detect acetylation of this histone. This might
be explained by the fact that our experiments utilized the
HAT-domain of the enzyme rather than the full-length
Figure 8. Nuclear distribution of p66a and p66b depends on CR2 and K149
for p66a. NIH3T3 cells were transfected with the indicated constructs coding
for various EGFP-fused p66-proteins. Cells were stained with ‘Hoechst DNA
stain’ and phase contrast images (left), Hoechst stain fluorescence (middle)
and EGFP fluorescence (right) was visualized.
Figure 9. Nuclear distribution of p66a and p66b depends on the presence of
MBD2. MBD2+/+ wild-type or MBD2 /  knock-out fibroblast cells were
transfected with constructs coding for the indicated EGFP-fused p66-proteins.
Images were taken as in Figure 8.
404 Nucleic Acids Research, 2006, Vol. 34, No. 2enzyme. In any case, acetylation of the core histones (H2A,
H2B, H3, H4) results in a decondensed chromatin structure
and correlates with transcriptional activity. Again, loss of
interaction upon acetylation of histone tails may be charge
driven although acetylation per se does not reduce p66 binding
as shown for the interaction with acteylated PCAF. A scenario
in which a DNA bound repressor, that mediates chromatin
histone deacetylation by initial unstable recruitment of a cor-
epressor complex, has recently been shown for the SMRT/
N-CoR complex (40). In this case, a stable two-interaction
binding mediated by the DNA bound factor as well as by
histone tails is observed only after deacetylation. Here, we
suggest a similar two-interaction mode of the Mi-2/NuRD
complex, which requires DNA binding by MBD2 as well as
histone tail binding. The CR2-mediated speckled nuclear dis-
tribution may be caused by an unknown function of CR2 or
histone tail binding of CR2 is involved in targeting of p66 as
well. In such a scenario, a forward feedback loop can be
envisaged, with a stable chromatin association taking place
only after deacetylation of the histones has occurred. Such a
stable Mi-2/NuRD binding might also facilitate a spreading
of inactive deacetylated chromatin into active chromatin
regions. Alternatively, histone association may play a role
during remodeling rather during targeting of the complex to
chromatin.
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Supplementary Data are available at NAR Online.
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